SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-20-003917
Filing Date
2020-04-15
Accepted
2020-04-15 16:15:43
Documents
4
Period of Report
2020-06-09
Effectiveness Date
2020-04-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20200609xdef14a.htm DEF 14A 876137
2 GRAPHIC tmb-20200609xdef14ag001.jpg GRAPHIC 6518
3 GRAPHIC tmb-20200609xdef14ag002.gif GRAPHIC 101671
4 GRAPHIC tmb-20200609xdef14ag003.gif GRAPHIC 84160
  Complete submission text file 0001558370-20-003917.txt   1142434
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37719 | Film No.: 20793871
SIC: 2834 Pharmaceutical Preparations